Marketing-authorisation holder · United States
Galderma Labs Lp
25 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · United States
25 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
25 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AKLIEF0.005% · Cream | Trifarotene | United States | Marketed | 2019 |
| CAPEX0.01% · Shampoo | Fluocinolone acetonide | United States | Not marketed | 1990 |
| CLOBEX0.05% · Shampoo | Clobetasol | United States | Marketed | 2004 |
| CLOBEX0.05% · Spray | Clobetasol | United States | Marketed | 2005 |
| CLOBEX0.05% · Lotion | Clobetasol | United States | Marketed | 2003 |
| DESOWEN0.05% · Cream | Desonide | United States | Marketed | 1984 |
| DESOWEN0.05% · Lotion | Desonide | United States | Not marketed | 1992 |
| DESOWEN0.05% · Ointment | Desonide | United States | Not marketed | 1988 |
| DIFFERIN0.1% · Lotion | Adapalene | United States | Not marketed | 2010 |
| DIFFERIN0.1% | 0.3% · GEL | Adapalene | United States | Marketed | 1996 |
| DIFFERIN0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Adapalene | United States | Not marketed | 1996 |
| DIFFERIN0.1% · Cream | Adapalene | United States | Marketed | 2000 |
| EPIDUO0.1%; 2.5% · GEL | Adapalene, Benzoyl peroxide | United States | Marketed | 2008 |
| EPIDUO FORTE0.3%; 2.5% · GEL | Adapalene, Benzoyl peroxide | United States | Marketed | 2015 |
| METROCREAM0.75% · Cream | Metronidazole | United States | Marketed | 1995 |
| METROGEL0.75% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1% · GEL | Metronidazole | United States | Marketed | 1988 |
| METROLOTION0.75% · Lotion | Metronidazole | United States | Marketed | 1998 |
| METVIXIA16.8% base · Cream | Methyl aminolevulinate | United States | Not marketed | 2004 |
| MIRVASO0.33% base · GEL | Brimonidine | United States | Marketed | 2013 |
| NEMLUVIO30mg | 30MG · Injectable | Nemolizumab | United States | Marketed | 2024 |
| ORACEA40mg · Capsule | Doxycycline | United States | Marketed | 2006 |
| PERIOSTAT20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Doxycycline | United States | Not marketed | 2001 |
| SOOLANTRA1% · Cream | Ivermectin | United States | Marketed | 2014 |
| TRI-LUMA0.01%; 4%; 0.05% · Cream | Fluocinolone acetonide, Hydroquinone, Tretinoin | United States | Marketed | 2002 |
| VECTICAL3mcg/gm · Ointment | Calcitriol | United States | Marketed | 2009 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 25 | 25 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.